Clinical Trials Browser

INDUSTRY × SGN-LIV1A × Clear all

Breast Neoplasms

NCT03310957 2025-12-12

Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer

Phase 1/2 Completed

185 enrolled 23 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04032704 2025-03-10

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

Phase 2 Terminated

205 enrolled 54 charts

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Melanoma, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT01969643 2023-03-07

A Safety Study of SGN-LIV1A in Breast Cancer Patients

Phase 1 Completed

290 enrolled

Breast

Neoplasm Metastasis, Triple Negative Breast Neoplasms

Clinical Trials

Morpheus-panBC

Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

A Safety Study of SGN-LIV1A in Breast Cancer Patients